GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Mediq N.V. (XAMS:MEDIQ) » Definitions » Capex-to-Revenue

Mediq N.V. (XAMS:MEDIQ) Capex-to-Revenue : 0.01 (As of Jun. 2012)


View and export this data going back to . Start your Free Trial

What is Mediq N.V. Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Mediq N.V.'s Capital Expenditure for the three months ended in Jun. 2012 was €-4.10 Mil. Its Revenue for the three months ended in Jun. 2012 was €647.10 Mil.

Hence, Mediq N.V.'s Capex-to-Revenue for the three months ended in Jun. 2012 was 0.01.


Mediq N.V. Capex-to-Revenue Historical Data

The historical data trend for Mediq N.V.'s Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mediq N.V. Capex-to-Revenue Chart

Mediq N.V. Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11
Capex-to-Revenue
Get a 7-Day Free Trial - 0.02 0.01 0.01 0.01

Mediq N.V. Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.01

Competitive Comparison of Mediq N.V.'s Capex-to-Revenue

For the Medical Devices subindustry, Mediq N.V.'s Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mediq N.V.'s Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Mediq N.V.'s Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Mediq N.V.'s Capex-to-Revenue falls into.



Mediq N.V. Capex-to-Revenue Calculation

Mediq N.V.'s Capex-to-Revenue for the fiscal year that ended in Dec. 2011 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-23.195) / 2657.705
=0.01

Mediq N.V.'s Capex-to-Revenue for the quarter that ended in Jun. 2012 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-4.1) / 647.1
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mediq N.V.  (XAMS:MEDIQ) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Mediq N.V. Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Mediq N.V.'s Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Mediq N.V. (XAMS:MEDIQ) Business Description

Traded in Other Exchanges
N/A
Address
Website

Mediq N.V. (XAMS:MEDIQ) Headlines

No Headlines